GSK-3β Can Regulate the Sensitivity of MIA-PaCa-2 Pancreatic and MCF-7 Breast Cancer Cells to Chemotherapeutic Drugs, Targeted Therapeutics and Nutraceuticals

Glycogen synthase kinase-3 (GSK-3) is a regulator of signaling pathways. KRas is frequently mutated in pancreatic cancers. The growth of certain pancreatic cancers is KRas-dependent and can be suppressed by GSK-3 inhibitors, documenting a link between KRas and GSK-3. To further elucidate the roles o...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Cells
Hoofdauteurs: Abrams, Stephen L., Akula, Shaw M., Meher, Akshaya K., Steelman, Linda S., Gizak, Agnieszka, Duda, Przemysław, Rakus, Dariusz, Martelli, Alberto M., Ratti, Stefano, Cocco, Lucio, Montalto, Giuseppe, Cervello, Melchiorre, Ruvolo, Peter, Libra, Massimo, Falzone, Luca, Candido, Saverio, McCubrey, James A.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: MDPI 2021
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8067414/
https://ncbi.nlm.nih.gov/pubmed/33917370
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells10040816
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items